Risk factors for muscle complaints and fatigue in CML patients on TKI therapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26541

Enrollment

140

Registered

2018-06-20

Start date

2018-05-17

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CML, chronic myeloid leukemia, chronische myeloïde leukemie.

Interventions

None

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with CML Aged >=18 years

Exclusion criteria

Exclusion criteria: Aged <18 years

Design outcomes

Primary

Measure	Time frame
Muscle complaints Fatigue	—

Secondary

Measure	Time frame
Physical activity, BMI, daily fluid intake	—

Contacts

Public ContactLando Janssen

024-3614468Lando.Janssen@radboudumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)